China’s government recently enacted new regulations on a number of industries, which has caused some investor concern. Franklin Templeton’s Emerging Markets Equity team follows up some of its initial commentary on the matter here, noting policies do not have a uniform effect on companies. READ MORE
Similar Posts:
- Heightened Regulatory Scrutiny in China: What Investors Need to Know (Franklin Templeton)
- Health Care: The Next Wave of Innovation in China (Franklin Templeton)
- Evergrande Crisis and Contagion Risks (Franklin Templeton)
- Investor Sentiment Survey: What Emerging Market Investors Think (Franklin Templeton)
- Templeton’s Chow: “No Reason the Goat and the Bull Cannot be Friends” (Mobius Blog)
- Evergrande and China: A Lehman Moment—or Less “Grande” Than That? (Franklin Templeton)
- Looking Past the Hang-Ups for Asia’s Smartphone Industry (Franklin Templeton)
- EXS Capital’s Solberg: China’s Property and Steel Sectors Look Interesting Now (CMN)
- The Race to Harness AI Technology in Asia (Franklin Templeton)
- China: Navigating the Regulatory Landscape (UBS AM)
- South Korea: A Shining Example of Emerging Market Leadership (Franklin Templeton)
- The New Emerging Markets Landscape: Policy Improvements Should Contribute to Increased Resilience (Franklin Templeton)
- Dr. Mark Mobius Announces Plans to Retire from Franklin Templeton Investments
- It’s Time for Investors to Reevaluate Their China Exposures (Investments & Wealth Monitor)
- Russia, Ukraine and China (Franklin Templeton)
